Search clinical trials for: Allogeneic peripheral blood stem cell

Total 6349 results

Stanford University
National Institutes of Health (NIH)

Completed

High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin | Blood and Marrow Transplant (BMT) | Lymphomas: Non-Hodgkin

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease

Myelodysplastic Syndromes | Leukemia | Graft Versus Host Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome

Mycosis Fungoides | Sezary Syndrome

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma

Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Non-Hodgkin Lymphoma

United States
M.D. Anderson Cancer Center
Cytogen Corporation

Completed

Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases

Breast Cancer | Bone Metastases

United States
American Regent, Inc.

Completed

Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding

Iron Deficiency Anemia
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS

Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Refractory Anemia With Excess Blasts

United States
American CryoStem Corporation

Active, not recruiting

ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion

Post-Concussion Syndrome

United States
huishengai

Completed

Randomized Study of HLA-mismatched DSI to Treat Relapse Leukemia After HLA- Matched Transplantation

Relapse Leukemia

China
Chaitanya Hospital, Pune

Unknown

Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Spinal Cord Injury (SCI)

Spinal Cord Injury.

India
L.V. Prasad Eye Institute

Not yet recruiting

To Evaluate the Clinical Safety and Efficacy of Limbal Stem Cell for Treatment of Superficial Corneal Pathologies".

Corneal Scars and Opacities
Boehringer Ingelheim

Completed

Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) (INBUILD®)

Lung Diseases, Interstitial

United States, Spain, Belgium, Germany, Canada, Korea, Republic of, Italy, United Kingdom, France, Chile, China, Japan, Poland, Russian Federation, Argentina
Shenzhen University General Hospital

Recruiting

Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Lymphoma (CAR-T)

Non-hodgkin Lymphoma,B Cell

China
University Hospital Tuebingen

Completed

Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma

Germany
Stanford University
National Institutes of Health (NIH)

Completed

Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders

Myelodysplastic Syndromes | Myeloproliferative Disorders | Myelodysplastic Syndromes (MDS) | Blood and Marrow Transplant (BMT) | Myeloproliferative Disorders (MPD)

United States
Seoul National University Hospital

Terminated

Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion

Myocardial Infarction

Korea, Republic of
Instituto do Coracao

Unknown

TRACS STUDY: Transfusion Requirements After Cardiac Surgery (TRACS)

Cardiac Surgery

Brazil
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

Refractory Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Hematopoietic Cell Transplantation Recipient

United States
Anterogen Co., Ltd.

Completed

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-101 Clinical Trial

Diabetic Foot Ulcer
Sun Yat-sen University

Unknown

Allogenic Bone Marrow Stem Cells Transplantation in Patients With Liver Cirrhosis

Liver Cirrhosis

China
Sun Yat-sen University

Unknown

Allogenic Bone Marrow Stem Cell Transplantation in Liver Failure

Liver Failure

China
Longeveron Inc.
The Emmes Company, LLC

Completed

AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery (CRATUS)

Frailty

United States
Fondazione Policlinico Universitario Agostino Gemelli...
Associazione Italiana per la Ricerca sul Cancro

Unknown

Up-front Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients Aged 65-75

Acute Myeloid Leukemia, Adult

Italy
Northside Hospital, Inc.

Completed

Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Withdrawn

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent... and other conditions

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Recruiting

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Leukemia | Myelodysplastic Syndrome

United States
General Hospital of Chinese Armed Police Forces

Unknown

A New Method to Treat Hereditary Cerebellar Ataxia - Umbilical Cord Mesenchymal Stem Cells Transplantation (SCA)

Hereditary Cerebellar Ataxia.

China
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy in Muscular Dystrophy

Muscular Dystrophy

India
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy in Mental Retardation

Mental Retardation

India
Neurogen Brain and Spine Institute

Withdrawn

Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

India
Neurogen Brain and Spine Institute

Withdrawn

Autologous Stem Cell Therapy in Stroke

Stroke

India
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy in Incurable Neurological Disorders

Neurological; Disorder, Nervous System

India
Medipost Co Ltd.

Completed

The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease

Dementia of the Alzheimer's Type

Korea, Republic of
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML

Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditions

United States
Neurogen Brain and Spine Institute

Withdrawn

Cell Therapy in Limb Girdle Muscular Dystrophy

Limb Girdle Muscular Dystrophy

India
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy for Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

India
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy in Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

India
Roger Williams Medical Center

Terminated

Study of the Effectiveness of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Fibrin to Treat Chronic Wounds

Non Healing Wounds

United States
Rigshospitalet, Denmark

Completed

Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia

Myocardial Ischemia | Coronary Heart Disease

Denmark
Oslo University Hospital

Completed

Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma

Glioblastoma | Brain Tumor
The Medical Pavilion Bahamas

Not yet recruiting

Allogeneic Cord Blood for Neurological Diseases in Adults

Stroke | Neurological Diseases | Spinal Cord Injuries
Children's Hospital of Chongqing Medical University

Unknown

Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia

Bronchopulmonary Dysplasia

China
Roswell Park Cancer Institute

Completed

Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer

Lymphoma | Brain and Central Nervous System Tumors | Neuroblastoma | Retinoblastoma

United States
Northwestern University

Completed

Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma

SYSTEMIC SCLERODERMA

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent... and other conditions

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...

Completed

Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia... and other conditions

United States
Help Therapeutics
Central South University

Recruiting

Allogeneic iPSC-derived Cardiomyocyte Therapy in Patients With Worsening Ischemic Heart Failure

Chronic Heart Failure | Ischemic Heart Failure

China
Boehringer Ingelheim

No longer available

An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs Who Have no Alternative Treatment Options

Lung Diseases, Interstitial

Belgium
Daping Hospital and the Research Institute of Surgery...
Children's Hospital of Chongqing Medical University; Chongqing Maternal and...

Withdrawn

Stem Cells for Bronchopulmonary Dysplasia

Bronchopulmonary Dysplasia

China
Celal Bayar University
The Scientific and Technological Research Council of Turkey; Acıbadem Labcell

Completed

Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria

Skin Diseases | Immune System Diseases | Autoimmune Diseases | Urticaria

Turkey

Search clinical trials for: Allogeneic peripheral blood stem cell

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations